Navigation Links
PediaVision to Conduct Spot Demonstrations During American Academy of Ophthalmology Annual Meeting

LAKE MARY, Fla., Oct. 18, 2011 /PRNewswire/ --WHO:David Melnik, President & CEO of PediaVisionJeff Mortensen, Vice President of PediaVisionWHAT:Will be conducting demonstrations of Spot, a revolutionary new vision screening device, which identifies vision problems in less than one second.WHEN:Wednesday, October 19, Thursday, October 20, Friday October 21 WHY:Spot is a new breakthrough vision screening device that will help children across America.  Spot has an incredibly quick capture time of less than one second which makes screening equally efficient in a physician's office or large-scale public screening. Spot is easily used by anyone when screening children from 6 months through adults.  URGENCY:

There is an on-going and urgent need for Spot.  The U. S. Centers for Disease Control and Prevention (CDC) state that vision disability is the single most prevalent disabling condition among children. Approximately 80 percent(1) of what children learn in their early school years is visual, so if they can't see a teacher's writing on the blackboard, they will struggle.(1)  American Optometric Association

SOURCE PediaVision
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. PediaVision Announces Record New Orders for Revolutionary New Vision Screening Device, Spot
2. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
3. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Maine Natural Health Company Conducts Dental Clinical Trial
8. Access Pharmaceuticals to Conduct Conference Call to Update Financial Community
9. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
10. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
11. Aon: Complex Insurance Requirements, Risk Management Needs Challenge Firms Conducting Clinical Trials Beyond Own Borders
Post Your Comments:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):